3osl
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
| - | [[Image:3osl. | + | [[Image:3osl.png|left|200px]] |
<!-- | <!-- | ||
| Line 12: | Line 12: | ||
===Structure of bovine thrombin-activatable fibrinolysis inhibitor in complex with tick carboxypeptidase inhibitor=== | ===Structure of bovine thrombin-activatable fibrinolysis inhibitor in complex with tick carboxypeptidase inhibitor=== | ||
| + | |||
| + | <!-- | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_20880845}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 20880845 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_20880845}} | ||
==About this Structure== | ==About this Structure== | ||
| Line 17: | Line 23: | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID:20088943</ref><ref group="xtra">PMID:18722183</ref><references group="xtra"/> | + | <ref group="xtra">PMID:20880845</ref><ref group="xtra">PMID:20088943</ref><ref group="xtra">PMID:18722183</ref><references group="xtra"/> |
[[Category: Bos taurus]] | [[Category: Bos taurus]] | ||
[[Category: Carboxypeptidase U]] | [[Category: Carboxypeptidase U]] | ||
| Line 36: | Line 42: | ||
[[Category: Hydrolase-hydrolase inhibitor complex]] | [[Category: Hydrolase-hydrolase inhibitor complex]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec 15 08:12:47 2010'' |
Revision as of 05:00, 15 December 2010
Structure of bovine thrombin-activatable fibrinolysis inhibitor in complex with tick carboxypeptidase inhibitor
Template:ABSTRACT PUBMED 20880845
About this Structure
3OSL is a 4 chains structure with sequences from Bos taurus and Rhipicephalus bursa. Full crystallographic information is available from OCA.
Reference
- Valnickova Z, Sanglas L, Arolas JL, Petersen SV, Schar C, Otzen D, Aviles FX, Gomis-Ruth FX, Enghild JJ. Flexibility of the thrombin-activatable fibrinolysis inhibitor pro-domain enables productive binding of protein substrates. J Biol Chem. 2010 Dec 3;285(49):38243-50. Epub 2010 Sep 29. PMID:20880845 doi:10.1074/jbc.M110.150342
- Sanglas L, Arolas JL, Valnickova Z, Aviles FX, Enghild JJ, Gomis-Ruth FX. Insights into the molecular inactivation mechanism of human activated thrombin-activatable fibrinolysis inhibitor. J Thromb Haemost. 2010 May;8(5):1056-65. Epub 2010 Jan 17. PMID:20088943 doi:10.1111/j.1538-7836.2010.03740.x
- Sanglas L, Valnickova Z, Arolas JL, Pallares I, Guevara T, Sola M, Kristensen T, Enghild JJ, Aviles FX, Gomis-Ruth FX. Structure of activated thrombin-activatable fibrinolysis inhibitor, a molecular link between coagulation and fibrinolysis. Mol Cell. 2008 Aug 22;31(4):598-606. PMID:18722183 doi:10.1016/j.molcel.2008.05.031
Page seeded by OCA on Wed Dec 15 08:12:47 2010
Categories: Bos taurus | Carboxypeptidase U | Rhipicephalus bursa | Arolas, J L. | Aviles, F X. | Enghild, J J. | Gomis-Ruth, F X. | Otzen, D. | Petersen, S V. | Sanglas, L. | Schar, C. | Valnickova, Z. | Alpha/beta-hydrolase-related fold | Blood | Coagulation | Fibrinolysis | Hydrolase-hydrolase inhibitor complex
